Physician profile
Sunayna Kumar
NPI 1619342086
$1,734.53
in general payments reported to CMS, 2019-2025
19 companies · $785 in 2025
The $785 reported for 2025 was more than what 81% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $87.93 · 2024: $861 · 2025: $785.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,734.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $322.48 | 2024-2025 | |
| Lilly USA, LLC | $277.36 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Exact Sciences Corporation | $249.45 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sumitomo Pharma America, INC. | $193.64 | 2024-2025 | Gemtesa |
| Glaxosmithkline, LLC. | $154.61 | 2024-2025 | Shingrix, Arexvy |
| Amgen INC. | $89.39 | 2024 | Repatha, Otezla |
| Abbvie INC. | $57.70 | 2025 | |
| Eisai INC. | $50.06 | 2025 | |
| Dynavax Technologies Corporation | $47.65 | 2023-2025 | Heplisav-B |
| Edwards Lifesciences Corporation | $43.05 | 2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Pfizer INC. | $42.87 | 2024-2025 | |
| Ipsen Biopharmaceuticals, INC | $34.25 | 2024 | |
| Novo Nordisk INC | $33.38 | 2025 | Wegovy |
| Globus Medical, INC. | $33.08 | 2025 | Senza |
| Kyowa Kirin, INC. | $26.54 | 2024 | Crysvita |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $23.37 | 2025 | Freestyle Libre 3 |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.93 | 2025 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.68 | 2025 | Xifaxan |
| Scilex Pharmaceuticals INC. | $14.04 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunayna Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.